InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.00
(
2.14%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,700.34
(
-0.31%
)
Post# of 423941
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jessellivermore

Send PM Follow Ignore
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

jessellivermore

Re: HDGabor post# 279770

Friday, 06/12/2020 2:42:30 PM

Friday, June 12, 2020 2:42:30 PM

Post# of 423941
G...

Quote.." Do you consider that a lot of plan tiering as:
1: preferred generics
2: non-preferred generics
3: preferred brand
2: non-preferred brand

Most is generic vs brand...if it is for the same indication..The important part is the indication is not what the doctor wants. It's what the drug plans determines from the FDA label...Although "off label prescribing" is perfectly legal..the drug plans usually stick to the label indication..They are not playing doctor..


Quote: "several companies produce gen Lovaza ... inc. TEVA"

ans. No doubt..

Quote: TEVA will produce gen Vascepa also.It will be Teva against Reddi and Hikma and Teva..

ans..no doubt...

How about the pricing of gen Lovaza by TEVA against gen Vascepa by TEVA ?

Interesting conjecture ...What do you think??? Teva did settle..I would not be surprised if they stick to GL...

":>) JL

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!